Artificial Intelligence
Cancer Supportive Care Drugs Market Size USD 25.78 BN by 2032
<!– Name:DistributionId Value:8790135 –> <!– Name:EnableQuoteCarouselOnPnr Value:False –> <!– Name:IcbCode Value: –> <!– Name:CustomerId Value:1213849 –> <!– Name:HasMediaSnippet Value:false –> <!– Name:AnalyticsTrackingId Value:8034f7f4-91f3-457c-8430-270320faeb62 –>
Ottawa, March 16, 2023 (GLOBE NEWSWIRE) — The cancer supportive care drugs market is expanding at a CAGR of 2.09% from 2023 to 2032. Rising cases of breast and lung cancer along with increasing geriatric population are directly linked with the development of cancer supportive care drugs market.
Key Insights
- Asia-Pacific region has generated revenue share of over 24.8% in 2022.
- U.S. market has generated 44.3% revenue share in 2022.
- The lung cancer and breast cancer has generated revenue share of 14.9% and 13.8% respectively in 2022.
- The granulocyte colony-stimulating factors (GCSFs) segment has captured revenue share of over 27% in 2022.
Get the sample pages of report@ https://www.precedenceresearch.com/sample/2665
Market overview:
Cancer supportive care drugs can refer to pain management drugs or medicines offered to cancer patients that have poorly responded to chemotherapy. The supportive care drugs for cancer patients can be delivered at every stage of cancer; the drugs or medication follow cancer patients throughout the treatment, particularly helping them to manage the adverse effects caused during the chemo sessions. In recent years, the healthcare administration has started offering cancer supportive care medicines or drugs to seriously ill patients at the beginning of cancer treatment; this avoids the risks of adverse experiences in the future. The recent advancements in the oncology sector have significantly improved the clinical outcomes of cancer supportive care drugs. Factors such as advancements in drug development methods, rising demand for generic drugs, increasing awareness of self-health care and a growing number of cancer diagnoses are expected to supplement the growth of the global cancer supportive care drugs market.
Report Highlights:
- By therapeutic class, being the primary treatment for supportive care, the Granulocyte Colony Stimulating Factors (GCSFs) segment dominates the market. GCSFs are widely utilized to manage neutropenia in cancer patients. Moreover, the antiemetics segment is anticipated to grow at a significant rate due to the rising demand for supportive care drugs for managing short-term side effects of chemotherapy, such as headache, vomiting and nausea.
- By application, the breast cancer segment is expected to hold a dominating share of the market during the period analyzed, owing to the rising prevalence of breast cancer across the globe. The treatment required for breast cancer is prolonged and tends to give long-term side effects, including hair loss, skin infections and infertility. Moreover, the rising concerns of anemia or bleeding caused by lung cancer treatment will increase the demand for supportive care drugs for lung cancer patients.
- By distribution channel, the hospital pharmacy segment dominates the market with a significant share. The preferences for cancer supportive care drugs from hospital pharmacies are rising due to the presence of professionals to make drug-based decisions for hospitalized cancer patients. The rising number of in-home healthcare settings is projected to boost the growth of the online pharmacy segment during the forecast period.
Ask here for customization study@ https://www.precedenceresearch.com/customization/2665
Scope of this report
| Report Coverage | Details |
| Market Size in 2032 | USD 25.78 Billion |
| By Therapeutic Class |
|
| By Application |
|
| By Distribution Channel |
|
| By Region |
|
| Key Players | Merck & Co., F. Hoffman-La Roche AG, Johnson & Johnson, Novartis AG, GlaxoSmithKline Plc, Helsin Healthcare SA, Baxter International Inc and Others |
Regional snapshot:
North America dominates the global cancer supportive care drugs market owing to the rising demand for advanced and innovative treatment for cancer patients in the region. The presence of major key players, including Amgen Inc., Merck & Co Inc., Johnson & Johnson Services and Heron Therapeutics, has contributed to the development of the cancer supportive care drugs market in North America. Moreover, the research and development (R&D) activities in the oncology sector in North America have been supplementing the growth of the market lately. Cancer remains the second most reason for deaths in the United States; the rising cancer cases in the country have forced the government and private sectors to enhance the budget for oncology research; this is another vital factor in boosting the growth of the cancer supportive care drugs market.
During the forecast period, Asia Pacific is expected to witness significant growth in the cancer supportive care drugs market. The improving healthcare infrastructure and rising biotechnology industry in developing countries of Asia Pacific are observed as powerful drivers for the growth of the market. According to the National Institutes of Health, as of 2022, the estimated number of cancer cases in India was 14,61 427. The rising prevalence of cancer in the country has forced the healthcare system to bring systematic supportive care methodologies for cancer patients. Along with India, China’s rising population and increasing geriatric population in Japan are observed to boost the requirement for cancer supportive care drugs in Asia Pacific.
The well-established healthcare infrastructure in Europe highlights the growth of the cancer supportive care drugs market. Moreover, leading market players, including Helsinn Healthcare SA, F. Hoffmann-La Roche Ltd., and GlaxoSmithKline Plc., are headquartered in Europe; this factor is considered to support the market development in the region. Moreover, advanced facilities for supportive and palliative care in economically established countries such as Germany, France and the UK are propelling the growth of the cancer supportive care drugs market in Europe.
Market dynamics:
Driver:
Rising prevalence of cancer in geriatric population
The risk of cancer increases with rising age. According to the National Institute of Cancer, more than one thousand per one lakh people develop cancer at the age of 60 or older. The rising cases of colorectal, lung and stomach cancer in the geriatric population are observed to boost the demand for cancer supportive care drugs. Due to the increasing number of damaged cells and reduced immunity, the geriatric population (people over 65) are more vulnerable to chronic diseases, including cancer. Cancer treatment can be complex and challenging for older people, as the body responds less to the therapy; complicated cancer treatments can be unbearable for older people. Thus, cancer supportive care drugs, along with palliative care, are highly recommended for the senior population as compared to the younger population.
Restraint:
Rising deployment of targeted therapies in cancer treatment
Targeted therapy is an advanced cancer treatment that targets cancer cell growth. The therapy or treatment is deployed all over owing to its unmatched benefits for cancer patients. In recent years, with proper clinical trials, the oncology sector has found multiple advantages of targeted therapies. Unlike chemotherapy, targeted therapy can quickly locate cancer cells and destroy them without harming healthy cells and tissues. Moreover, this therapy is less painful and causes comparatively fewer side effects. The rising clinical trials and deployment of targeted therapies for cancer patients will significantly lessen the chemotherapy practices across the globe, which is observed to harm the growth of the cancer supportive care drugs market during the forecast period.
Opportunity:
Technological advancements in oncology research sector
The rising demand for advanced cancer treatments with an increasing burden on the healthcare industry has forced the oncology research sector to rapidly adopt technological advancements to boost the speed of research and development. CRISPR, a gene editing technology; artificial intelligence, to improve the diagnosis; Infinium assay, a genotyping technique and numerous other technologies have helped researchers visualize ways to find better cancer treatments. Such technological advancements are intended to enhance the pace of research to bring more innovative cancer drugs to the market; this accelerates the market’s growth by providing lucrative opportunities to market players.
Challenge:
Stringent FDA regulations for approving drugs
Every pharmaceutical company and the newly developed drug must undergo the Food and Drug Administration regulations before commercializing the product. FDA monitors newly developed drugs’ efficacy and side effects before it goes to the market. The drug approval process of the FDA includes multiple stages such as drug safety monitoring, drug review, preclinical research, clinical research and post-market drug monitoring. The process for approval of new drugs is time-consuming and may cost a hefty amount to the pharmaceutical or biotech company; such rigorous process of FDA approval stretches the commercialization of the drug by creating a challenge for the market’s growth.
Recent Developments:
- In February 2023, the National Comprehensive Cancer Network announced a new strategic collaboration with the Institute of Hematology and Transfusion Medicine in Poland to improve cancer care by implementing evidence-based and advanced supportive care platforms.
- In February 2023, a leading biotechnology company, Moderna Inc and Merck, announced that mRNA-4157/C940, combined with KEYTRUDA, has received Breakthrough Therapy Designation (BDT) from the United States Food and Drug Administration. MRNA-4157/C940 is an investigational personalized cancer vaccine developed for patients with a high risk of melanoma.
- In March 2022, Australia-based, Imugene announced a new collaboration with Merck & Co. This collaboration aims to start clinical trials to evaluate the efficacy of HER-Vaxx, B-cell activating immunotherapy in combination with KEYTRUDA for patients with HER-2 positive gastric cancer.
Immediate Delivery Available | Buy This Premium Research Report@ https://www.precedenceresearch.com/checkout/2665
You can place an order or ask any questions, please feel free to contact at [email protected] | +1 9197 992 333
About Us
Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.
For Latest Update Follow Us:
https://www.linkedin.com/company/precedence-research/
https://www.facebook.com/precedenceresearch/
https://twitter.com/Precedence_R
Artificial Intelligence
Southeast Asia Data Center Construction Market Investment to Reach $5.29 Billion by 2029 – Exclusive Research Report by Arizton
CHICAGO, May 15, 2024 /PRNewswire/ — According to Arizton’s latest research report, the Southeast Asia data center construction market is growing at a CAGR of 11.69% during 2023-2029.
To Know More, Click: https://www.arizton.com/market-reports/southeast-asia-data-center-construction-market
Browse in-depth TOC on the Southeast Asia Data Center Construction Market
36 – Tables 116 – Figures 352 – Pages
Southeast Asia Data Center Construction Market Report Scope
Report Attributes
Details
Market Size – Investment (2029)
USD 5.29 Billion
Market Size – Investment (2023)
USD 2.80 Billion
CAGR – Investment (2023-2029)
11.18 %
Market Size – Area (2029)
3,079 Thousand Square Feet
Power Capacity (2029)
578 MW
Historic Year
2020-2022
Base Year
2023
Forecast Year
2024-2029
Regional Analysis
Southeast Asia (Singapore, Indonesia, Malaysia, Thailand, Philippines, Vietnam, and Other Southeast Asia Countries)
The Southeast Asia data center construction market is one of the fastest-developing markets globally, driven by the increase in cloud adoption, the advent of 5G services, and the adoption of AI, Big data, and IoT technology. Singapore, Malaysia, Indonesia, and Thailand have robust connectivity and are among the most connected countries in Southeast Asia. Singapore is the gateway and an integral interconnection point to several APAC countries, including Japan, South Korea, Vietnam, and Pakistan. The adoption of cloud-based services will likely be a significant driver of the data center market over the next few years.
Moreover, Singapore boasts the largest existing capacity in the region, and countries such as Malaysia, Indonesia, and the Philippines are outpacing it in terms of new investments, collectively capturing over 50% of the market share for new investments. This trend can be attributed to several factors, including lower energy costs, increased renewable energy sources, and inexpensive labor and land availability. These factors are influencing companies’ decisions to invest in these emerging markets.
Watch Out for How Advancing in Adoption of AI Boosting the Market Growth
In June 2023, Run ai, a company that manages computing resources for AI tasks, announced a strategic partnership with AI Singapore. AI Singapore, a national R&D initiative led by the National Research Foundation, Singapore, aims to establish strong AI capabilities in the country. This collaboration aims to provide scalable infrastructure solutions for various AI projects and assist AI Singapore in its mission to expedite AI adoption across industries.AI Singapore, as the country’s AI initiative, holds a pivotal position in aiding organizations in adopting AI solutions. It has made significant strides through its notable 100 Experiments Programme (100E) and the acclaimed AI Apprenticeship Programme (AIAP). Collaborating with over 60 companies, they’ve trained over 200 Singaporean AI engineers to create, assess, and implement numerous AI models that tackle real-world challenges.While AI investments primarily focus on Singapore, nine out of the top 10 deals involved start-ups based in Singapore that cater to various businesses and use cases throughout the region. For instance, Biofourmis, a health analytics platform analyzing physiological data from clinical-grade wearables, operates in both Singapore and Indonesia. Similarly, Tookitaki, a sophisticated decision-support system for compliance programs in the financial services sector, extends its operations across the six major Southeast Asian countries.The Southeast Asia Colocation Data Center Market by Investment to Reach $4 Billion by 2029
In Southeast Asia, colocation investments in Singapore declined significantly over the last few years owing to the lack of space for new builds. This has led to the spill over demand toward Indonesia and Malaysia. The upcoming capacity of under-construction announced and planned data center campuses across these two countries will overtake Singapore’s existing colocation capacity. In the same year, BDx Indonesia, Chindata Group, EdgeConneX, Equinix, Keppel Data Centres, GDS Services, Princeton Digital Group, and others invested in developing colocation data center facilities in the region.
The Southeast Asia Data Center Construction Market Report Encompasses Crucial Data, Including: CAGR (Compound Annual Growth Rate) during the forecast period: This metric provides insights into the annual growth rate of the Southeast Asia data center construction market over the specified time frame. Detailed information on growth drivers: The report offers in-depth information on the factors that will propel the Southeast Asia data center construction market growth from 2023 to 2029. This includes an analysis of various market influences. Precise estimation of market size: Accurate assessments of the Southeast Asia data center construction market size and its contribution and focusing on key market segments. Predictions about upcoming trends and changes in consumer behavior: The report offers insights into anticipated trends and shifts in consumer behavior that are likely to impact the Southeast Asia data center construction market helping businesses prepare for future market dynamics. Geographical market growth: The report covers the development of the data center construction market across Southeast Asia.Competitive landscape analysis: A thorough examination of the market’s competitive landscape is presented, including detailed information about companies operating in the Southeast Asia data center construction market. This includes an overview of key players, their market share, strategies, and key developments. Analysis of growth challenges: The report includes a comprehensive analysis of factors that may pose challenges to the growth of companies in the Southeast Asia data center construction market, providing a well-rounded view of the market dynamics.
Buy this Research @ https://www.arizton.com/market-reports/southeast-asia-data-center-construction-market
Post-Purchase Benefit
1hr of free analyst discussion10% off on customizationThe Report Includes the Investment in the Following Areas:
Facility Type
Colocation Data CentersHyperscale Data CentersEnterprise Data CentersInfrastructure
Electrical InfrastructureMechanical InfrastructureGeneral ConstructionElectrical Infrastructure
UPS SystemsGeneratorsTransfer Switches & SwitchgearPDUsOther Electrical InfrastructureMechanical Infrastructure
Cooling SystemsRacksOther Mechanical InfrastructureCooling Systems
CRAC & CRAH UnitsChiller UnitsCooling Towers, Condensers & Dry CoolersOther Cooling UnitsCooling Techniques
Air-based CoolingLiquid-based CoolingGeneral Construction
Core & Shell DevelopmentInstallation & Commissioning ServicesEngineering & Building DesignFire Detection & SuppressionPhysical SecurityDCIM/BMS SolutionsTier Standard
Tier I & IITier IIITier IVGeography
Southeast Asia
SingaporeIndonesiaMalaysiaThailandPhilippinesVietnamOther Southeast Asia CountriesVendors
Key Construction Contractors
ArupAurecon GroupCSF GroupDSCO GroupGammon ConstructionNTT FacilitiesPM GroupStudio One DesignOther Prominent Construction Contractors
AtkinsRéalisAWP ArchitectsCorganDPR ConstructionFirst BalfourFortis ConstructionISGKienta Engineering ConstructionLinesightLSK EngineeringM+W GroupNakano CorporationObayashi CorporationPowerware SystemsSato KogyoRed EngineeringProminent Support Infrastructure Vendors
ABBCaterpillarCisco SystemsCumminsDell TechnologiesEatonRittalSchneider ElectricSTULZVertivOther Prominent Support Infrastructure Vendors
AiredaleAlfa LavalCanovateCyber Power SystemsDelta ElectronicsEAEFuji ElectricFujitsuGreen Revolution CoolingHewlett Packard EnterpriseHITEC Power ProtectionHuawei TechnologiesKOHLER PowerLegrandLenovoMitsubishi ElectricNaradaNortek Air SolutionsPiller Power SystemsRolls-RoyceShenzhen Envicool TechnologySiemensSocomecTraneProminent Data Center Investors
Amazon Web ServicesChindata Group (Bridge Data Centres)DCI IndonesiaDigital RealtyePLDTEquinixGDS ServicesKeppel Data CentresNTT DATAST Telemedia Global Data CentresTelkom IndonesiaVADS (Telekom Malaysia)Viettel IDCOther Prominent Data Center Investors
AirTrunkBeeinfotechBig Data Exchange (BDx)Converge ICT SolutionsDigital Edge DCMeta (Facebook)FPT TelecomGoogleMettaDCMicrosoftOneAsia NetworkOpen DCPrinceton Digital GroupSingtelVantage Data CentersNew Entrants
CtrlS DatacentersDigital HaloEdgeConneXEvolution Data CentresFlow Digital InfrastructureFutureData (Cyclect Group + TSG Group)Gaw CapitalI-BerhadInfinaxis Data CentreInfracrowd CapitalK2 Data CentresMinoro Energi IndonesiaNautilus Data TechnologiesPure Data Centres GroupYCO CloudYTL Data CenterYondrKey Questions Answered in the Report:
How big is the Southeast Asia data center construction market?What is the estimated market size in terms of area in the Southeast Asia data center construction market by 2029?What is the growth rate of the Southeast Asia data center construction market?What are the key trends in the Southeast Asia data center construction market?How many MW of power capacity is expected to reach the Southeast Asia data center construction market by 2029?
Get Detailed TOC @ https://www.arizton.com/market-reports/southeast-asia-data-center-construction-market
Check Out Some of the Top Selling Research Reports:
U.S. Data Center Construction Market – Industry Outlook & Forecast 2024-2029
https://www.arizton.com/market-reports/united-states-data-center-construction-market-2024
Latin America Data Center Construction Market – Industry Outlook & Forecast 2024-2029
https://www.arizton.com/market-reports/latin-america-data-center-construction-market-size-and-analysis-2024
Southeast Asia Data Center Market Landscape 2023-2028
https://www.arizton.com/market-reports/southeast-asia-data-center-market
Why Arizton?
100% Customer Satisfaction 24×7 availability – we are always there when you need us 200+ Fortune 500 Companies trust Arizton’s report 80% of our reports are exclusive and first in the industry 100% more data and analysis 1500+ reports published till date
About Us:
Arizton Advisory and Intelligence is an innovative and quality-driven firm that offers cutting-edge research solutions to clients worldwide. We excel in providing comprehensive market intelligence reports and advisory and consulting services.
We offer comprehensive market research reports on consumer goods & retail technology, automotive and mobility, smart tech, healthcare, life sciences, industrial machinery, chemicals, materials, I.T. and media, logistics, and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.
Arizton comprises a team of exuberant and well-experienced analysts who have mastered generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.
Contact Us
Call: +1-312-235-2040 +1 302 469 0707 Mail: [email protected] Contact Us: https://www.arizton.com/contact-us Blog: https://www.arizton.com/blog Website: https://www.arizton.com/
Photo: https://mma.prnewswire.com/media/2413471/Aritzon_Data_Center_Infographic.jpgLogo: https://mma.prnewswire.com/media/818553/Arizton_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/southeast-asia-data-center-construction-market-investment-to-reach-5-29-billion-by-2029–exclusive-research-report-by-arizton-302146261.html
Artificial Intelligence
Doceree Launches HIEP to Unveil the Untapped Potential of Healthcare Digital Platforms
LONDON, May 15, 2024 /PRNewswire/ — Doceree, the leading global healthcare marketing platform building unprecedented programmatic solutions for HCP marketing, today announced the launch of its highly anticipated HIEP (High Interaction & Engagement Platforms) UK and Europe edition. Presented in collaboration with WPP’s healthcare specialist agency CMI Media Group, the groundbreaking report profiles endemic, point-of-care, and physician networking platforms in a digital engagement context, shedding light on their potential to power interactions and drive communications in the healthcare industry.
In the current landscape, the healthcare sector exhibits preference for an omnichannel marketing approach that effectively combines digital and traditional channels. This shift underscores the critical importance for pharmaceutical marketers to excel in digital strategies. Yet, challenges persist within the pharmaceutical and life sciences industries regarding the optimal selection of digital platforms to engage healthcare professionals (HCPs), as marketers often lack a comprehensive understanding of the available digital tools to formulate precise strategies for digital budget allocation.
To bridge this knowledge gap, and empower marketers with better engagement and decision-making, Doceree introduced HIEP as a medium that could help brands forge neatly choreographed digital strategies, thereby bringing efficiency to operations at scale and improve business outcomes. The report focuses on how the digital medium can be harnessed to create a win-win situation for all the stakeholders—marketers, in terms of efficiency; publishers, in terms of revenue; HCPs, for knowledge exchange and for better treatment outcomes.
Commenting on the report launch, Harshit Jain MD, Founder & Global CEO, Doceree, said, ” We are thrilled to introduce the HIEP report (UK/EU edition) as it marks a significant step forward in advancing healthcare marketing strategies in the UK and Europe and leveraging the power of digital platforms to engage HCPs effectively in the region. What’s particularly exciting is how marketers can effortlessly map and track HCPs’ digital interactions and engagement, and fine-tune omnichannel marketing campaigns, to ultimately amplifying impact and generate superior returns on investment with HIEP. We anticipate that this report will greatly benefit our pharmaceutical and agency partners in the UK & Europe region, and we are eager to replicate this success in other regions throughout the year”.
Commenting on the initiative, Joe Warren, EVP, Growth, CMI Media Group, said, “Collaborating with Doceree on the HIEP initiative allows us to shed light on the global impact marketers can make in healthcare. This partnership reaffirms our commitment to enhancing healthcare outcomes in the region and underscores the importance of understanding channels and partners for crafting superior omnichannel strategies. Together, we aim to drive awareness and empower marketers with the insights they need to make a meaningful impact in healthcare marketing.”
Key highlights of the HIEP report include:
In-depth analysis of endemic, point-of-care, and physician networking platformsCase studies showcasing successful integration of digital platforms in healthcare marketingRecommendations for optimizing omnichannel marketing campaigns and maximizing ROIThe report by Doceree has been meticulously crafted in collaboration with research partner Brand Innerworld and is proudly presented in association with CMI Media Group, a distinguished global media agency recognized for its significant contributions to the healthcare sector.
For more information about Doceree and the HIEP report, visit https://doceree.com/in/reports/hiep/
About Doceree:
Doceree is a leading global platform dedicated to revolutionizing HCP programmatic messaging with cutting-edge, proprietary data tools. By fostering direct messaging between life sciences brands and HCPs, Doceree enables the delivery of personalized communications through an extensive global network of digital endemic and point-of-care platforms. The result is transparent marketing campaign metrics and personalized messaging at scale. To explore how Doceree can transform your healthcare communication. Learn more at www.doceree.com.
About CMI Media Group:
CMI Media Group, a WPP company (NYSE: WPP, http://www.wpp.com), is a full-service media agency focused solely on health, wellness, and pharmaceutical marketing. CMI Media Group’s core offerings include Audience Strategy, Planning, Development, and Insights; Data and Analytics; Buying and Investment; and Direct Response and Customer Experience. As the leading media resource for the world’s top healthcare companies, CMI Media Group brings together leading technology, data, and talent to deliver seamless capabilities for clients. CMI Media Group has been recognized as a leader in DE&I, talent retention and employee development as well as one of the industry’s best places to work. Visit https://cmimediagroup.com/.
About Brand Innerworld:
Brand Innerworld is a leading healthcare brand consultancy and insight mining firm providing specialized solutions with the help of AI technology. The consultancy is dedicated to transforming healthcare brands into market leaders. With meticulous primary and secondary research, the firm captures deep insights into the experiences of healthcare professionals and patients. Specializing in blending these insights with marketing and media acumen, Brand Innerworld equips healthcare brands with actionable strategies that enhance patient outcomes and brand growth. Serving multinational healthcare corporations, medical device companies, and tech platforms, Brand Innerworld is recognized for its innovative approach to medical marketing. Learn more about Brand Innerworld at https://brandinnerworld.com
Photo – https://mma.prnewswire.com/media/2413865/Doceree_HIEP_Report.jpgLogo – https://mma.prnewswire.com/media/1758952/Doceree_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/doceree-launches-hiep-to-unveil-the-untapped-potential-of-healthcare-digital-platforms-302146584.html
Artificial Intelligence
Trianz Appoints Ravishankar Savita as Head of Data & Analytics Practice, Reaffirming Commitment to Data-Driven Transformation Excellence
SANTA CLARA, Calif., May 15, 2024 /PRNewswire/ — Digital transformation technology & services company Trianz is pleased to announce the appointment of Ravishankar Savita as the Head of Data & Analytics Practice. With over two decades of experience in technology transformation and system engineering, Ravishankar brings a wealth of strategic leadership and expertise in architecting and leading large scale digital transformation to Trianz.
Ravishankar’s appointment marks a pivotal moment for Trianz as it reaffirms its commitment to redefine the digital landscape through an “IP Led” model, leveraging its cutting-edge hyper-automated platforms, including Concierto.Cloud, Extrica.AI, and Pulse. Ravishankar’s demonstrated success in scaling practices, cultivating innovation ecosystems, and fostering strategic partnerships position him as a key asset in spearheading the Data & Analytics Practice.
“We are thrilled to welcome Ravishankar Savita to Trianz as our new Head of Data & Analytics Practice,” said Seshi Vanguru, Chief Revenue Officer at Trianz. “His strategic acumen, strong analytical skills, and exceptional ability to cultivate meaningful relationships will play a pivotal role in driving tangible business outcomes and fostering sustainable growth within our Data & Analytics Practice. As we continue to innovate and deliver transformative solutions to our clients, Ravishankar’s leadership will undoubtedly strengthen our commitment to driving value and excellence in the data-driven era.”
Ravishankar’s distinguished career includes senior leadership roles at renowned organizations such as Virtusa, Agilent Technologies, and NXP Semiconductors, where he incubated and scaled high performing offerings, platforms, and teams to drive business value in Data & Analytics, AI, API Integration, Microservices, SDLC Automation, Middleware Solutions, Application Modernization, and Generative AI.
“I am excited to join Trianz and lead the Data & Analytics Practice during this transformative era of digital evolution,” said Ravishankar. “I look forward to collaborating with the exceptional team at Trianz to deliver innovative solutions that not only meet but exceed our clients’ expectations. By leveraging cutting-edge, IP-led solutions, we’ll not only redefine the industry standards but also solidify our reputation as the go-to partner for forward-thinking organizations seeking to unlock the full potential of their data assets.”
Based in New Jersey, US, Ravishankar will leverage his expertise to accelerate Trianz’s growth trajectory in the data-driven landscape. Join us in extending a warm welcome to Ravishankar as we set out on this exciting journey to drive digital innovation and empower businesses to thrive in the data-driven era.
About TrianzTrianz is a leading-edge technology platforms and services company that accelerates digital transformations at Fortune 100 and emerging companies worldwide in data & analytics, digital experiences, cloud infrastructure, and security. Our “IP Led Transformations” approach, informed by insights from a recent global study spanning 20+ industries and 5000+ companies, addresses challenges posed by the rapid pace of AI-driven transformation, digital talent scarcity, and economic uncertainty. Our IP and platforms, including Concierto, Extrica, and Pulse, revolutionize cloud adoption, data analytics, and AI insights, empowering organizations to navigate the complexities of digital transformation seamlessly.
Founded in California and with an organization of over 2,000 associates across the United States and India, Trianz is a Premier Partner of AWS, consistently rated #1 by clients for value delivery over the past five years. Trianz has been ranked as one of the best Consulting Firms by Forbes and has been certified as a Great Place to Work for three years in a row. To learn more about Trianz, email [email protected] or visit www.trianz.com.
Watch Trianz CEO Sri Manchala’s insightful interview with Bloomberg on Partner | Crossing The Digital Faultline & Leading Towards Transformative Success – YouTube and delve deeper into his book Crossing the Digital Faultline at Crossing the Digital Faultline | Trianz.
Trianz Media Team
[email protected] +1-408-387-5800
Logo: https://mma.prnewswire.com/media/626944/1199800/Trianz_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/trianz-appoints-ravishankar-savita-as-head-of-data–analytics-practice-reaffirming-commitment-to-data-driven-transformation-excellence-302146066.html
-
Artificial Intelligence5 days agoSanad Announces Strategic Sale Transaction with CFM Materials, Further Fostering Aviation Industry Collaborations
-
Artificial Intelligence5 days agoNorthern Data Group’s Peak Mining announces new partnership for 28MW of mining, powered by 100% renewable energy
-
Artificial Intelligence5 days agoIdentity Threat Detection and Response (ITDR) Market worth $35.6 billion by 2029- Exclusive Report by MarketsandMarkets™
-
Artificial Intelligence5 days ago
atNorth Shortlisted for Datacloud Global Awards, The Energy Awards and The Women in Green Business Awards
-
Artificial Intelligence5 days agoWIO Taps Gracenote to Revolutionize Television Broadcast Reporting
-
Artificial Intelligence6 days ago
Linnovate Partners Announces Close of USD 40 Million Funding Commitment Led by SeaTown
-
Artificial Intelligence6 days ago
CoreWeave Invests £1 Billion in UK; Opens New European Headquarters and Data Centres in London to Bring Cloud Infrastructure to Power the AI Revolution
-
Artificial Intelligence5 days agoProofID wins Judges’ Award for Global Ambition at the 2024 Northern Tech Awards
